The estimated Net Worth of Elizabeth Burr is at least $200 Thousand dollars as of 21 April 2022. Ms. Burr owns over 91 units of Rite Aid stock worth over $59 and over the last 6 years she sold RAD stock worth over $0. In addition, she makes $199,716 as Independent Director at Rite Aid.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ms. Burr RAD stock SEC Form 4 insiders trading
Elizabeth has made over 1 trades of the Rite Aid stock since 2022, according to the Form 4 filled with the SEC. Most recently she exercised 91 units of RAD stock worth $59 on 21 April 2022.
The largest trade she's ever made was exercising 91 units of Rite Aid stock on 21 April 2022 worth over $59. On average, Elizabeth trades about 6 units every 0 days since 2019. As of 21 April 2022 she still owns at least 91 units of Rite Aid stock.
You can see the complete history of Ms. Burr stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Elizabeth Burr biography
Elizabeth Burr is Independent Director of the Company. Ms. Burr most recently served as the chief innovation officer and vice president of healthcare trend and innovation at Humana where she was responsible for driving the design, build and adoption of new product platforms in digital health, provider experience, and telemedicine, to improve health outcomes, create superior member experiences, and improve health care costs. She also founded Humana’s strategic investing practice, Humana Health Ventures. Prior to joining Humana in 2015, Burr was managing director of Citi Ventures and led large-scale business transformation efforts as the global head of Citi’s Business Incubation Function-DesignWorks. Earlier in her career, Burr spent seven years in investment banking at Morgan Stanley and Credit Suisse First Boston and previously served as vice president of global brand management at Gap, Inc. Burr holds an MBA from Stanford University and a bachelor’s degree in Economics from Smith College.
What is the salary of Elizabeth Burr?
As the Independent Director of Rite Aid, the total compensation of Elizabeth Burr at Rite Aid is $199,716. There are 15 executives at Rite Aid getting paid more, with Heyward Donigan having the highest compensation of $8,619,340.
How old is Elizabeth Burr?
Elizabeth Burr is 57, she's been the Independent Director of Rite Aid since 2019. There are 9 older and 11 younger executives at Rite Aid. The oldest executive at Rite Aid Corp. is Arun Nayar, 69, who is the Independent Director.
What's Elizabeth Burr's mailing address?
Elizabeth's mailing address filed with the SEC is 8950 CYPRESS WATERS BLVD., , COPPELL, TX, 75019.
Insiders trading at Rite Aid
Over the last 45 years, insiders at Rite Aid have traded over $704,219,544 worth of Rite Aid stock and bought 1,989,612 units worth $9,286,101 . The most active insiders traders include Coutu Group (Pjc) Inc. Jean, John M Baumer, and Equity Investors Iii Lpgei .... On average, Rite Aid executives and independent directors trade stock every 238 days with the average trade being worth of $2,811,488. The most recent stock trade was executed by Heyward R Donigan on 22 December 2021, trading 14,350 units of RAD stock currently worth $199,896.
What does Rite Aid do?
riteaid is a company based out of 7189 henry clay blvd, liverpool, new york, united states.
What does Rite Aid's logo look like?
Complete history of Ms. Burr stock trades at SVB, Rite Aid, and Mr. Cooper Inc
Rite Aid executives and stock owners
Rite Aid executives and other stock owners filed with the SEC include:
-
Heyward Donigan,
President, Chief Executive Officer, Director -
Heyward Rutledge Donigan B.A.,
Pres CEO & Director -
Jocelyn Konrad,
Executive Vice President - Pharmacy and Retail Operations -
Matthew Schroeder,
Chief Financial Officer, Senior Vice President -
James Peters,
Chief Operating Officer -
Jocelyn Zazyczny Konrad,
Exec. VP & Chief Pharmacy Officer -
James Joseph Peters Jr.,
Chief Operating Officer -
Matthew C. Schroeder,
CFO & Exec. VP -
Justin L. Mennen,
Exec. VP & Chief Information Officer -
Bruce Bodaken,
Independent Chairman of the Board -
Louis Miramontes,
Independent Director -
Arun Nayar,
Independent Director -
Kevin Lofton,
Independent Director -
Robert Knowling,
Independent Director -
Marcy Syms,
Independent Director -
Elizabeth Burr,
Independent Director -
Katherine Quinn,
Independent Director -
Bari Harlam,
Independent Director -
Paul Gilbert,
General Counsel, Company Secretary -
Brian Hoover,
Chief Accounting Officer -
Roxanne Schwans,
Senior Vice President - Market Access and Pharmacy Purchasing -
Angele Robinson-Gaylord,
Senior Vice President - Store Development -
Chris Bohrer,
Senior Vice President - Payor and Strategic Initiatives -
Trent Kruse,
Senior Vice President of Investor Relations, Treasury -
Erik Keptner,
Senior Vice President, Chief Marketing Officer -
Justin Mennen,
Senior Vice President, Chief Information Officer -
Andre Persaud,
Executive Vice President - Retail -
Susan K. Henderson,
Chief Communications Officer & Sr. VP -
Paul D. Gilbert,
Exec. VP, Gen. Counsel & Corp. Sec. -
Byron Purcell,
Sr. Director of Treasury Services & Investor Relations -
Brian T. Hoover,
Chief Accounting Officer & Sr. VP -
Michel Coutu,
Director -
James Donald,
Director -
Steven Bixler,
Chief Accounting Officer -
Bryan B Everett,
CHIEF OPERATING OFFICER -
Frank A Savage,
Director -
Michael N Regan,
Director -
Myrtle S Potter,
Director -
Joseph B Jr Anderson,
Director -
Castle Dedra Newman,
EVP -
David Jessick,
Director -
John T Standley,
Senior EVP & CAO -
David Abelman,
EVP -
Tony Montini,
EVP -
Darren W Karst,
EVP & CFO -
Kermit R Crawford,
President and COO -
Jessica Kazmaier,
EVP, Chief HR Officer -
James J Comitale,
EVP, General Counsel, Secy. -
Matt Schroeder,
EVP, Chief Financial Officer -
Derek S. Griffith,
Field EVP, Store Operations -
Benjamin Bulkley,
CEO EnvisionRXOptions -
Kenneth Martindale,
Senior Executive VP -
Andre Belzile,
Director -
Dennis Wood,
Director -
Philip G Satre,
Director -
Robert Gerald Miller,
Director -
Pierre Legault,
Senior EVP - CAO -
Equity Investors Iii Lpgree...,
-
Stuart M Sloan,
Director -
Douglas E Donley,
Senior VP and CAO -
Colin V Reed,
Director -
Robert Sari,
SVP AND GENERAL COUNSEL and -
Michael A Friedman,
Director -
Jonathan Ddanhakl John G So...,
-
George Golleher,
Director -
Robert J Easley,
Chief Operating Officer -
Mary F Sammons,
PRESIDENT & CEO -
Bruin Jerry Mark De,
EVP, Pharmacy -
Mark C Panzer,
SR. EVP - Store Operations -
Alfred Gleason,
Director -
Equity Investors Iii Lpgree...,
-
Kevin Twomey,
SVP & CHIEF ACCOUNTING OFFICER -
Robert A Mariano,
Director -
James P Mastrian,
SR.EVP.- Category Management -
Christopher Hall,
EVP and CFO -
Robert K Thompson,
EVP -
Robert Ivan Thompson,
EVP - Pharmacy -
Frank Vitrano,
Chief Admin. Officer & CFO -
Marc A Strassler,
EVP,General Counsel -
Coutu Group (Pjc) Inc. Jean,
10% owner -
Brian Fiala,
Executive VP, Operations -
Equity Investors Iii Lpgei ...,
-
John M Baumer,
Director -
Francois J Coutu,
Director -
Dan Robson,
President, EnvisionRXOptions -
Ray Smithberger,
SVP, Operations